Clinical Trials Browser

Completed × Carcinoma, Ductal, Breast × Paclitaxel × Clear all

NCT02779855 2026-03-10

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Phase 1/2 Completed

50 enrolled 12 charts

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Ductal, Triple Negative Breast Neoplasms

NCT01583426 2020-08-06

GeparSepto

Phase 3 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT00096343 2018-12-04

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

Phase 2 Completed

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Inflammatory Breast Neoplasms

NCT02125344 2017-07-13

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Phase 3 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT02199418 2017-01-25

SHPD001

Phase 2 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT01426880 2016-02-15

GeparSixto

Phase 2/3 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms